Empowering Urologic Health
Innovation that’s changing the standard of care
Blue Halo Biomedical, LLC is a research and development company providing a better way to drain the bladder for improved health outcomes, enhanced patient lifestyles, and significant reduction in healthcare cost.
For patients who rely on catheters, innovation can make a world of difference. Blue Halo has developed a pipeline of breakthrough technology solutions. With a targeted 2026 new product release, the fully-internal Hammond Hodge Hybrid Urethral Stent (H2HUS) has proven to be safe, effective and well-tolerated among patients in clinical trials.
Better urine flow leads to better lives for urologic patients. Blue Halo is committed to enhancing daily life and well-being through innovative design.